Showing 4071-4080 of 5771 results for "".
- FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-001 for the Treatment of Stargardt Diseasehttps://modernod.com/news/fda-grants-alkeus-pharmaceuticals-breakthrough-therapy-designation-for-alk-001-c20-d3-vitamin-a-for-the-treatment-of-stargardt-disease/2479374/Alkeus Pharmaceuticals announced that the FDA has granted Breakthrough Therapy Designation to ALK-001 for the treatment of Stargardt Disease. ALK-001 (C20-D3-vitamin A) is a chemically-modified form of vitamin A developed to treat multiple retinal degenerati
- Hoya Vision Care and Myopia Profile Training the Visionaries of the Futurehttps://modernod.com/news/hoya-vision-care-and-myopia-profile-training-the-visionaries-of-the-future/2479370/Hoya Vision Care announced the roll out of a suite of co-created certified training courses to educate, inform and empower eye care professionals (ECPs) to prescribe spectacle lenses for children in the global fight t
- Envision Sets Agenda for 2021 Virtual Conference Easthttps://modernod.com/news/envision-sets-agenda-for-2021-virtual-conference-east/2479371/Envision announced that it has finalized the agenda for its August 2021 Conference, a 2-day event to be livestreamed on August 20-21. Envision Virtual Conference East 2021 is a multidisciplinary event focused on disseminating the latest advancements in rehabilitation techniques and research and t
- Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trialshttps://modernod.com/news/dopavision-closes-e12-million-series-a-round-to-advance-digital-childhood-myopia-therapeutic-through-clinical-trials/2479372/Dopavision announced the closing of a €12 million Series A financing round. The proceeds will be used to fund the clinical development of MyopiaX, the company’s lead product in childhood myopia, with the goal to demonstrate its safety and efficacy in clinical studies and advance this innova
- Zeiss Introduces Fully Integrated, Data-Driven Medical Ecosystemhttps://modernod.com/news/zeiss-introduces-fully-integrated-data-driven-medical-ecosystem/2479366/During a virtual press conference on Tuesday, Zeiss announced the launch of a new medical ecosystem. The ecosyste
- Nicox Appoints Robert N. Weinreb, MD, and Sanjay G. Asrani, MD, to its Glaucoma Clinical Advisory Boardhttps://modernod.com/news/nicox-appoints-robert-n-weinreb-md-and-sanjay-g-asrani-md-to-its-glaucoma-clinical-advisory-board/2479362/Nicox SA announced that two internationally recognized experts in glaucoma, Robert N. Weinreb, MD, Distinguished Professor and Chair, Ophthalmology and Director, Shiley Eye Institute, University of California San Diego; and Sanjay G. Asrani, MD, Professor of Ophthalmology, Duke University, will b
- Ocuphire to Present at Multiple Ophthalmic Conferences in Julyhttps://modernod.com/news/ocuphire-to-present-at-multiple-ophthalmic-conferences-in-july/2479363/Ocuphire Pharma announced that Jay S. Pepose, MD, Medical Advisor and Board Director, will be presenting two papers on presbyopia and reversal of mydriasis (RM) at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting on July 23-27, 2021 and that Mina Sooch, CEO and
- AMA Assigns CPT Code to Software Designed to Treat Adult Amblyopia (Lazy Eye)https://modernod.com/news/ama-assigns-cpt-code-to-software-designed-to-treat-adult-amblyopia-lazy-eye/2479361/RevitalVision announced that its standalone therapeutic vision training software, the only FDA-approved product for market, and clinically proven to improve vision in adult amblyopia (age 9-plus), received a unique Current Procedural Terminology (CPT) reimbursement code from the American Medical
- Opthea’s OPT-302 Granted FDA Fast Track Designation for Wet AMDhttps://modernod.com/news/optheas-opt-302-granted-fda-fast-track-designation-for-wet-amd/2479360/Opthea has announced FDA has granted Fast Track designation for the company’s VEGF-C/-D ‘trap’ inhibitor, OPT-302, in combination with anti-VEGF-A therapy for the treatment of patients with wet age-related macular degeneration (AMD). The FDA’s Fast Track pro
- Bausch + Lomb Launches Biotrue Hydration Boost Lubricant Eye Drops and Biotrue Micellar Eyelid Cleansing Wipeshttps://modernod.com/news/bausch-lomb-launches-biotrue-hydration-boost-lubricant-eye-drops-and-biotrue-micellar-eyelid-cleansing-wipes/2479359/Bausch + Lomb announced the US launch of Biotrue Hydration Boost Lubricant Eye Drops and Biotrue Micellar Eyelid Cleansing Wipes. Both products are preservative-free and formulated with naturally inspired ingredients to relieve symptoms associated with irritated, dry eyes. “One of the majo